Erez Offer, Hoppensteadt Debra, Romero Roberto, Espinoza Jimmy, Goncalves Luis, Nien Jyh Kae, Kusanovic Juan Pedro, Fareed Jawed, Gotsch Francesca, Pineles Beth, Chaiworapongsa Tinnakorn
Perinatology Research Branch, NICHD, NIH, DHHS Bethesda, Maryland, USA.
J Matern Fetal Neonatal Med. 2007 Sep;20(9):661-7. doi: 10.1080/14767050701495011.
Protein Z, a vitamin K-dependent plasma protein, has an important role in the regulation of the coagulation cascade. Protein Z deficiency has been associated with unexplained pregnancy loss and adverse pregnancy outcome in patients with thrombophilia. This study was conducted to determine if preeclampsia (PE), small for gestational age (SGA), and fetal demise are associated with changes in maternal plasma concentrations of protein Z.
This cross-sectional study included normal pregnant women (N = 71), patients with PE (N = 130), patients who delivered an SGA neonate (N = 58), and patients with fetal demise (N = 58). Maternal plasma protein Z concentrations were measured by a sensitive and specific immunoassay. Protein Z deficiency was defined as maternal plasma concentrations <or=5th percentile of the normal pregnancy group (<or=1.59 microg/mL). Non-parametric statistics were used for analysis.
(1) Patients with PE had a lower median plasma concentration of protein Z than normal pregnant women (PE: median 1.6 microg/mL, range 0.2-3.3 microg/mL vs. normal pregnancy: median 2.4 microg/mL, range 1.1-3.4 microg/mL; p < 0.0001); (2) patients with an SGA neonate (median 2.3 microg/mL, range 0.2-3.8 microg/mL) and fetal demise (median 2.6 microg/mL, range 0.2-4.3 g/mL) did not have significantly different median protein Z concentrations from normal pregnant women (p > 0.05); and (3) women in the PE and fetal demise groups had significantly higher rates of protein Z deficiency than those with normal pregnancy outcome.
(1) PE, but not SGA or fetal demise, is associated with a significantly lower maternal median plasma concentration of protein Z than normal pregnancy, and (2) a high rate of protein Z deficiency is observed in patients with PE and fetal demise.
蛋白Z是一种维生素K依赖的血浆蛋白,在凝血级联反应调节中起重要作用。蛋白Z缺乏与血栓形成倾向患者不明原因的流产和不良妊娠结局有关。本研究旨在确定子痫前期(PE)、小于胎龄儿(SGA)和胎儿死亡是否与母体血浆蛋白Z浓度变化有关。
这项横断面研究纳入了正常孕妇(N = 71)、PE患者(N = 130)、分娩SGA新生儿的患者(N = 58)和胎儿死亡患者(N = 58)。采用灵敏且特异的免疫测定法测量母体血浆蛋白Z浓度。蛋白Z缺乏定义为母体血浆浓度≤正常妊娠组第5百分位数(≤1.59μg/mL)。采用非参数统计进行分析。
(1)PE患者的血浆蛋白Z中位浓度低于正常孕妇(PE:中位值1.6μg/mL,范围0.2 - 3.3μg/mL;正常妊娠:中位值2.4μg/mL,范围1.1 - 3.4μg/mL;p < 0.0001);(2)分娩SGA新生儿的患者(中位值2.3μg/mL,范围0.2 - 3.8μg/mL)和胎儿死亡患者(中位值2.6μg/mL,范围0.2 - 4.3μg/mL)的蛋白Z中位浓度与正常孕妇无显著差异(p > 0.05);(3)PE组和胎儿死亡组女性的蛋白Z缺乏率显著高于妊娠结局正常的女性。
(1)与正常妊娠相比,PE与母体血浆蛋白Z中位浓度显著降低有关,而SGA或胎儿死亡则不然;(2)在PE患者和胎儿死亡患者中观察到较高的蛋白Z缺乏率。